PCK1 and hepatocellular carcinoma: YAP1 suppresses the expression of PCK1 by inhibiting the binding of peroxisome proliferator-activated receptor gamma coactivator 1 (PGC1α) to gluconeogenesis gene promoter, which leads to the activation of gluconeogenesis pathway and the progress of HCC.